These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 22350218

  • 21. MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle.
    Morosetti R, Mirabella M, Gliubizzi C, Broccolini A, De Angelis L, Tagliafico E, Sampaolesi M, Gidaro T, Papacci M, Roncaglia E, Rutella S, Ferrari S, Tonali PA, Ricci E, Cossu G.
    Proc Natl Acad Sci U S A; 2006 Nov 07; 103(45):16995-7000. PubMed ID: 17077152
    [Abstract] [Full Text] [Related]

  • 22. Characterization of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis.
    Horvath R, Fu K, Johns T, Genge A, Karpati G, Shoubridge EA.
    J Neuropathol Exp Neurol; 1998 May 07; 57(5):396-403. PubMed ID: 9596410
    [Abstract] [Full Text] [Related]

  • 23. Proteomic analysis of inclusion body myositis.
    Li J, Yin C, Okamoto H, Jaffe H, Oldfield EH, Zhuang Z, Vortmeyer AO, Rushing EJ.
    J Neuropathol Exp Neurol; 2006 Aug 07; 65(8):826-33. PubMed ID: 16896316
    [Abstract] [Full Text] [Related]

  • 24. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D, Schleinitz N, Boutière-Albanèse B, Camoin L, Bardin N, Guis S, Pouget J, Cognet C, Pellissier JF, Dignat-George F.
    J Rheumatol; 2006 Aug 07; 33(8):1623-30. PubMed ID: 16881117
    [Abstract] [Full Text] [Related]

  • 25. Downregulation of adenine nucleotide translocator 1 exacerbates tumor necrosis factor-α-mediated cardiac inflammatory responses.
    Pan S, Wang N, Bisetto S, Yi B, Sheu SS.
    Am J Physiol Heart Circ Physiol; 2015 Jan 01; 308(1):H39-48. PubMed ID: 25380814
    [Abstract] [Full Text] [Related]

  • 26. Sporadic inclusion body myositis: morphology, regeneration, and cytoskeletal structure of muscle fibres.
    Arnardottir S, Borg K, Ansved T.
    J Neurol Neurosurg Psychiatry; 2004 Jun 01; 75(6):917-20. PubMed ID: 15146016
    [Abstract] [Full Text] [Related]

  • 27. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.
    Larman HB, Salajegheh M, Nazareno R, Lam T, Sauld J, Steen H, Kong SW, Pinkus JL, Amato AA, Elledge SJ, Greenberg SA.
    Ann Neurol; 2013 Mar 01; 73(3):408-18. PubMed ID: 23596012
    [Abstract] [Full Text] [Related]

  • 28. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers.
    Wójcik S, Engel WK, McFerrin J, Askanas V.
    Acta Neuropathol; 2005 Aug 01; 110(2):173-7. PubMed ID: 15983828
    [Abstract] [Full Text] [Related]

  • 29. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
    De Paepe B, Creus KK, Martin JJ, Weis J, De Bleecker JL.
    Ann N Y Acad Sci; 2009 Sep 01; 1173():463-9. PubMed ID: 19758187
    [Abstract] [Full Text] [Related]

  • 30. Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis.
    Vattemi G, Nogalska A, King Engel W, D'Agostino C, Checler F, Askanas V.
    Acta Neuropathol; 2009 May 01; 117(5):569-74. PubMed ID: 19280202
    [Abstract] [Full Text] [Related]

  • 31. Pleomorphic mitochondrial and different filamentous inclusions in inflammatory myopathies associated with mtDNA deletions.
    Molnar M, Schröder JM.
    Acta Neuropathol; 1998 Jul 01; 96(1):41-51. PubMed ID: 9678512
    [Abstract] [Full Text] [Related]

  • 32. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B.
    Presse Med; 2003 Oct 25; 32(35):1656-67. PubMed ID: 14631270
    [Abstract] [Full Text] [Related]

  • 33. Expression of granulysin in polymyositis and inclusion-body myositis.
    Ikezoe K, Ohshima S, Osoegawa M, Tanaka M, Ogawa K, Nagata K, Kira JI.
    J Neurol Neurosurg Psychiatry; 2006 Oct 25; 77(10):1187-90. PubMed ID: 16980658
    [Abstract] [Full Text] [Related]

  • 34. Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy.
    Zanusso G, Vattemi G, Ferrari S, Tabaton M, Pecini E, Cavallaro T, Tomelleri G, Filosto M, Tonin P, Nardelli E, Rizzuto N, Monaco S.
    Brain Pathol; 2001 Apr 25; 11(2):182-9. PubMed ID: 11303793
    [Abstract] [Full Text] [Related]

  • 35. Messenger RNA degradation may be inhibited in sporadic inclusion body myositis.
    Nakano S, Shinde A, Ito H, Ito H, Kusaka H.
    Neurology; 2005 Aug 09; 65(3):420-5. PubMed ID: 16087907
    [Abstract] [Full Text] [Related]

  • 36. Evidence for heterogeneity of T cell expansion in polymyositis and inclusion body myositis.
    van der Meulen MF, van Wichen DF, van Blokland WT, van den Berg LH, Wokke JH, Hoogendijk JE, de Weger RA.
    J Neuroimmunol; 2002 Dec 09; 133(1-2):198-204. PubMed ID: 12446023
    [Abstract] [Full Text] [Related]

  • 37. Intracellular phosphates in inclusion body myositis--a 31P magnetic resonance spectroscopy study.
    Argov Z, Taivassalo T, De Stefano N, Genge A, Karpati G, Arnold DL.
    Muscle Nerve; 1998 Nov 09; 21(11):1523-5. PubMed ID: 9771678
    [Abstract] [Full Text] [Related]

  • 38. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
    Das L, Blumbergs PC, Manavis J, Limaye VS.
    Appl Immunohistochem Mol Morphol; 2013 Dec 09; 21(6):539-42. PubMed ID: 23343957
    [Abstract] [Full Text] [Related]

  • 39. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
    Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L.
    Arthritis Rheum; 1997 May 09; 40(5):865-74. PubMed ID: 9153548
    [Abstract] [Full Text] [Related]

  • 40. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ, Mhiri C, Chazaud B, Christov C, Cherin P, Barlovatz-Meimon G, Gherardi RK.
    Neuropathol Appl Neurobiol; 1997 Apr 09; 23(2):132-40. PubMed ID: 9160898
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.